Powerful Medical, a leading innovator in AI-driven cardiovascular diagnostics trusted by over 100,000 healthcare providers internationally, announces the release of its all new PMcardio for Individuals 3.0 across Europe. This update significantly improves the speed and accuracy of ECG interpretation, empowering clinicians to make critical decisions in acute cardiovascular care—where every second counts.
"In acute cardiovascular care, every second is crucial, and immediate clarity is invaluable. PMcardio for Individuals 3.0 was developed from the ground up and empowers clinicians during critical moments—delivering instant, explainable ECG interpretations. By detecting STEMI and STEMI equivalents, we ensure healthcare professionals have the insights they need to act decisively and confidently in emergency scenarios," said Viktor Jurasek, Chief Product Officer at Powerful Medical.
The cornerstone of PMcardio 3.0 is the newest STEMI AI ECG Model, the Queen of Hearts™ algorithm, detecting STEMI and STEMI-equivalents and specifically tuned for rapid identification of both clear and subtle occlusive myocardial infarction (OMI) cases. OMI patients frequently present without classic STEMI patterns, yet require the same immediate recognition and intervention to minimize cardiac damage as classic STEMI patients.
To further empower healthcare providers, PMcardio’s signature AI ECG explainability feature, ECGxplain™, generates lead-specific diagnostic heatmaps, visualizing the rationale behind the AI's ECG interpretation. This transparency facilitates more confident clinical decision-making in acute care scenarios, particularly during urgent clinical situations.
The updated PMcardio for Individuals now features automated ECG digitization and format detection to further simplify workflows by instantly recognizing and adapting to various ECG formats, saving valuable time in emergency settings.
Clinically evaluated in 19 international independent studies, PMcardio consistently demonstrates double the diagnostic accuracy of traditional ECG algorithms and standard of care ECG interpretations. The new PMcardio for Individuals mobile application continues to offer comprehensive coverage, including 36 core ECG diagnoses—ranging from critical arrhythmias and heart blocks to conduction abnormalities—as well as automatic calculation of 12 essential ECG measurements, such as heart rate, PR, QRS, and QT/QTc intervals.
Powerful Medical also offers PMcardio for Organizations, an AI-powered care coordination platform designed to integrate seamlessly into health systems. This enterprise solution standardizes diagnostic pathways and accuracy across the entire health systems, ensuring consistent, high-quality ECG interpretation and rapid triage and care coordination for cardiovascular patients. By connecting all stakeholders and deeply integrating with hospital IT infrastructure—ranging from emergency department teams and nursing staff to cardiologists —PMcardio for Organizations enables efficient decision-making, reduces misdiagnosis, and optimizes the activation of resources, improving both patient outcomes and operational efficiency.
For more information about PMcardio and its cutting-edge technology, visit www.powerfulmedical.com.
Powerful Medical is a medical device manufacturer committed to transforming cardiac care through AI-powered ECG diagnostics. Their flagship solution, PMcardio, is clinically validated to detect STEMI and STEMI equivalents up to three hours earlier and with twice the sensitivity of the current standard of care—enabling timely and accurate triage in emergency settings. Already on the market with EU MDR CE-mark in Europe, PMcardio is enhancing clinical decision-making in critical situations, enabling faster, more accurate management for patients with acute cardiac conditions.